Therefore, IL-7 can affect the immune balance of IgG4-RD patients by promoting the expansion and function of CD4+CD28- CTLs and CD8+CD28- CTLs in IgG4-RD through the JAK pathway. This evidence concerns the gene CD8A and immunoglobulin G4-related sclerosing disease.